Corix Bioscience Equity 2024

Corix Bioscience Aktienanalyse

What does Corix Bioscience do?

Corix Bioscience is a company specialized in the production of cannabinoid-based products. It was founded in 2014 under the name American Housing Income Trust, a holding company focused on the American real estate market. In 2017, the company decided to restructure and change its name to Corix Bioscience. Since then, the company has become one of the leading manufacturers of CBD oils and other cannabinoid-based products. Corix Bioscience's business model is based on state-of-the-art technologies and innovation in the cannabinoid industry. The company collaborates with other firms to develop new products tailored to patient needs. The company aims to provide patients with a natural and safe alternative to conventional medical therapy. Corix Bioscience has five divisions. These include "Corix Bioscience," which focuses on the development of CBD-based products for the European market. "Corix Health" develops cannabinoid-based products specifically tailored to patient needs. "Subsidiaries" is responsible for collaborating with other companies to expand the product offering. "Licensing" offers licenses for technologies and rights to use innovative products. "Research and Development" focuses on advancing research and technologies in the cannabinoid industry. One of Corix Bioscience's most well-known products is CBD oil. It is extracted from specially bred hemp plants and is used for pain relief, anxiety, and other ailments. The company also offers CBD-based cosmetic products and food. Corix Bioscience is headquartered in Fresno, California, and is now internationally active. The company places special emphasis on the quality of its products and uses only natural and certified ingredients. Corix Bioscience advocates for fair and sustainable production and focuses on environmental protection and sustainability. The future prospects for Corix Bioscience are promising. The company operates in a forward-thinking market, focusing on innovation and sustainability. The developments in the market for cannabinoid-based products allow Corix Bioscience to expand its portfolio and offer more patients a natural alternative to conventional medical therapy. Corix Bioscience ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Corix Bioscience's Equity

Corix Bioscience's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Corix Bioscience's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Corix Bioscience's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Corix Bioscience's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Corix Bioscience’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Corix Bioscience stock

What is the equity of Corix Bioscience this year?

Corix Bioscience has equity of 0 USD this year.

What was the equity of Corix Bioscience compared to the previous year?

The equity of Corix Bioscience has increased/decreased by 0% decreased compared to the previous year.

What impact does a high equity have on investors of Corix Bioscience?

A high equity is advantageous for investors of Corix Bioscience as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Corix Bioscience?

A low equity can be a risk for investors of Corix Bioscience, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Corix Bioscience affect the company?

An increase in equity of Corix Bioscience can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Corix Bioscience affect the company?

A reduction in equity of Corix Bioscience can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Corix Bioscience?

Some factors that can affect the equity of Corix Bioscience include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Corix Bioscience so important for investors?

The equity of Corix Bioscience is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Corix Bioscience take to change the equity?

To change equity, Corix Bioscience can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Corix Bioscience pay?

Over the past 12 months, Corix Bioscience paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Corix Bioscience is expected to pay a dividend of 0 USD.

What is the dividend yield of Corix Bioscience?

The current dividend yield of Corix Bioscience is .

When does Corix Bioscience pay dividends?

Corix Bioscience pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Corix Bioscience?

Corix Bioscience paid dividends every year for the past 0 years.

What is the dividend of Corix Bioscience?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Corix Bioscience located?

Corix Bioscience is assigned to the 'Health' sector.

Wann musste ich die Aktien von Corix Bioscience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Corix Bioscience from 9/26/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/26/2024.

When did Corix Bioscience pay the last dividend?

The last dividend was paid out on 9/26/2024.

What was the dividend of Corix Bioscience in the year 2023?

In the year 2023, Corix Bioscience distributed 0 USD as dividends.

In which currency does Corix Bioscience pay out the dividend?

The dividends of Corix Bioscience are distributed in USD.